{"infobox":{"dc_creator":"WooScraper_v1","dc_date_year":2023,"dc_description":"Hoort bij <a href='https://open.overheid.nl/Details/4f83bcd7-b51c-4095-acb2-93214e7d6325/3'>Kamerbrief over analyse early access programma\u2019s voor geneesmiddelen in andere landen</a>. Minister Helder (VWS) informeert de Tweede Kamer over hoe andere landen omgaan met\n               de \n               beschikbaarstelling van geneesmiddelen na de markttoelatingstoets, in afwachting \n               op een definitief vergoedingsbesluit.","dc_identifier":"nl.mnre1025.2e-b.2023.999","dc_publisher":"mnre1025","dc_publisher_name":"Ministerie Van Volksgezondheid, Welzijn En Sport","dc_source":"https://open.overheid.nl/Details/7344b6db-f9ae-44bb-affb-db33c1c9fdd6/3","dc_title":"Beslisnota bij Kamerbrief over analyse early access programma\u2019s voor geneesmiddelen in andere landen","dc_type":"2e-b","dc_type_description":"2e-b - Advies: Beslisnota","foi_decisionDate":"2023-12-21","foi_extraMetadata":{},"foi_fairiscoreVersions":{"v1":5,"v2":5},"foi_files":[{"dc_format":"application/pdf","dc_identifier":"nl.mnre1025.2e-b.2023.999.doc.1","dc_source":"https://open.overheid.nl/documenten/7344b6db-f9ae-44bb-affb-db33c1c9fdd6/file","dc_title":"Beslisnota bij Kamerbrief over Analyse early access programma_s voor geneesmiddelen in andere landen","dc_type":"bijlage","foi_doc_missing":0,"foi_fairiscoreVersions":{"v1":5,"v2":5},"foi_fileName":"Beslisnota bij Kamerbrief over Analyse early access programma_s voor geneesmiddelen in andere landen.pdf","foi_nrPages":2}],"foi_isWoo":"Ja","foi_nrDocuments":1,"foi_nrPagesInDossier":2,"foi_page_title":"Advies: Beslisnota Ministerie Van Volksgezondheid, Welzijn En Sport","foi_publishedDate":"2024-01-22","foi_retrievedDate":"2024-01-23","tooiwl_type":"c_99a836c7"},"resource":"nl.mnre1025.2e-b.2023.999"}